Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction  by Guy, T.Sloane et al.
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revention of Ischemic Mitral Regurgitation
oes Not Influence the Outcome of
emodeling After Posterolateral Myocardial Infarction
. Sloane Guy IV, MD,* Sina L. Moainie, MD,* Joseph H. Gorman III, MD,* Benjamin M. Jackson, MD,*
heodore Plappert, CVT,† Yoshiharu Enomoto, MD,* Martin G. St. John-Sutton, MBBS, FACC,†
. Henry Edmunds, JR, MD,* Robert C. Gorman, MD*
hiladelphia, Pennsylvania
OBJECTIVES This study was designed to test the hypothesis that ischemic mitral regurgitation (IMR)
results from, but does not influence, the progression of left ventricular (LV) remodeling after
posterolateral infarction.
BACKGROUND Surgical correction of chronic IMR is being increasingly recommended.
METHODS Three groups of sheep had coronary snares placed around the second and third obtuse
marginal coronary arteries. Occlusion of these vessels in the control group resulted in
progressive IMR over eight weeks. In a second group, Merseline mesh was fitted to cover the
exposed LV before infarction. In a third group, a ring annuloplasty was placed before infarction
to prevent IMR. Remodeling and degree of IMR were assessed with echocardiography at
baseline and at 30 min and two, five, and eight weeks after infarction.
RESULTS Eight weeks after infarction, mean IMR grade was significantly higher in control animals
than mesh and annuloplasty animals. At eight weeks, LV end-systolic volume and
end-systolic muscle-to-cavity-area ratio (ESMCAR) were significantly better in mesh-
treated sheep than in control sheep; also, at eight weeks, ESMCAR and akinetic segment
length were significantly better in mesh-treated sheep than in annuloplasty sheep.
Ejection fraction was significantly higher in the mesh than the annuloplasty group. There
was no significant difference in any measure of remodeling between the annuloplasty and
control groups.
CONCLUSIONS Prophylactic ventricular restraint reduces infarct expansion, attenuates adverse remodeling,
and reduces IMR severity. Prevention of IMR by prophylactic ring annuloplasty does not
influence remodeling. Ischemic mitral regurgitation is a consequence, not a cause, of
postinfarction remodeling; infarct expansion is the more important therapeutic
target. (J Am Coll Cardiol 2004;43:377–83) © 2004 by the American College of
Cardiology Foundationw
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pyocardial infarctions (MIs) often initiate a remodeling
rocess that leads to gross ventricular distortion, contractile
ysfunction of normally perfused myocardium, symptomatic
ongestive heart failure (CHF), and premature death (1,2).
See page 384
epending on size, location, and transmurality of the
nfarct, the remodeling process may be associated with the
evelopment of ischemic mitral regurgitation (IMR) (1–5).
ild degrees of mitral regurgitation after acute MI portend
substantially increased risk of cardiovascular mortality
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igns of overt CHF (6).
Increasing awareness of the poor prognosis associated
ith IMR has stimulated much debate regarding the best
reatment for these patients. Valve replacement or (prefer-
bly) valve repair are being increasingly recommended even
or moderate IMR, especially when coronary bypass grafting
s indicated. However, careful assessment of the most recent
nd thoroughly analyzed surgical series leads to the conclu-
ion that surgical intervention for IMR provides little
enefit compared to medical therapy for CHF (4,7). The
esults are predictable and sobering: a steady, almost linear
oss of patients, culminating in a five-year survival of 50%
4,7,8).
These clinical results suggest that IMR is a consequence
f postinfarction remodeling and does not itself contribute
o the progression of the phenomenon. Early infarct expan-
ion is associated with the development of progressive
entricular dilation (1,9), a myopathic process in normally
erfused myocardium (10,11), and poor long-term progno-
is (1). We therefore hypothesized that infarct expansion is
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Ischemic MR and Ventricular Remodeling February 4, 2004:377–83he major stimulus for adverse remodeling and greatly
utweighs any contribution from gradually progressive mi-
ral valve incompetence.
We tested the hypothesis using a well-established sheep
odel of chronic IMR in which the development of IMR
as prevented by prophylactic ring annuloplasty in one
roup of animals and infarct expansion was minimized by
entricular restraint in another.
ETHODS
urgical protocol. Twenty-two Dorset male hybrid sheep
Animal Biotech Industries, Doylestown, Pennsylvania)
eighing 35 to 40 kg were used for this study. Animals were
reated under an experimental protocol approved by the
niversity of Pennsylvania’s Institutional Animal Care and
se Committee (IACUC) and in compliance with NIH
ublication No. 85-23 as revised in 1985.
Animals were induced with thiopental sodium (10 to 15
g/kg intravenously [IV]) and intubated. Anesthesia was
aintained with isofluorane (1.5% to 2%) and oxygen. All
nimals received glycopyrrolate (0.4 mg IV) and enrofloxin
10 mg/kg IV) on induction.
Under aseptic conditions, all animals underwent left
horacotomy. Polypropylene snares were loosely placed
round the second and third obtuse marginal branches of
he circumflex artery supplying the posterolateral LV wall
12). Group assignment was random. Ten animals (control
roup) underwent closure of the thoracotomy and recovery.
ive animals (annuloplasty group) underwent placement of
24-mm mitral annuloplasty ring (Carpentier-Edwards
hysio, Edwards Life Science, Irvine, California) using
tandard cardiac surgical techniques. Following termination
f cardiopulmonary bypass and decannulation, these ani-
als underwent closure of the thoracotomy and were
ecovered. Seven animals (wrap group) had an appropriately
ized piece of Merseline mesh sutured in place over the LV
rom base to apex and from left anterior descending coro-
ary artery to posterior descending coronary artery; these
nimals, too, then underwent thoracotomy closure and
Abbreviations and Acronyms
ANOVA  analysis of variance
CHF  congestive heart failure
EF  ejection fraction
ESMCAR  end-systolic muscle-to-cavity-area ratio
IMR  ischemic mitral regurgitation
IV  intravenous
LV  left ventricle
LVEDV  left ventricular end-diastolic volume
LVESV  left ventricular end-systolic volume
LVP  left ventricular pressure
MI  myocardial infarction
WMA  wall motion abnormalityecovery. iaseline data and infarction. Fourteen days after initial
nstrumentation, sheep were again anesthetized. The surface
lectrocardiogram (ECG) and arterial blood pressure were
ontinuously monitored (Sonometrics Inc., London, Can-
da) and recorded during all data collection procedures. A
igh-fidelity pressure transducer (SPC-350, Millar Instru-
ents Inc., Houston, Texas) was inserted via a femoral
rtery into the left ventricle (LV) for continuous pressure
LVP) monitoring (78534c monitor, Hewlett-Packard, Palo
lto, California). A pulmonary artery catheter (131-h, 7fr,
axter Healthcare Corp, Deerfield, Illinois) was placed;
hermodilution cardiac output was measured in triplicate at
ach time point for each animal. Animals were disconnected
rom the ventilator and atrially paced at 120 beats/min for
ll measurements and echocardiograms.
After baseline hemodynamic and echocardiographic data
ere recorded, the subcutaneous snares were exposed, tight-
ned, and tied to produce infarction. Each animal received
agnesium sulfate (1 g IV), bretylium (10 mg/kg IV), and
idocaine (3 mg/kg IV bolus, then 2 mg/min infusion)
efore infarction. Hemodynamic and echocardiographic
ata were collected 30 min after infarction.
chocardiography. Quantitative two-dimensional subdia-
hragmatic echocardiograms were obtained before infarc-
ion and at 30 min and 2, 5, and 8 weeks after infarction (1)
sterile midline laparotomy (or right or left subcostal
ncision) was made and subdiaphragmatic two-dimensional
chocardiographic images were obtained using a 5 MHz
robe (77020A, Hewlett Packard). Images were recorded
n VHS videotape at 30 Hz (Panasonic AG-6300 VHS
ecorder). Left ventricular short-axis images at three levels
the tips of the papillary muscles, the bases of the papillary
uscles, and the apex) and two orthogonal long-axis views
ere recorded. Previous reports validated the reproducibility
nd effectiveness of this technique for evaluating LV remod-
ling in sheep (13,14). Left ventricular volumes at end-
ystole (LVESV) and end-diastole (LVEDV) were calcu-
ated using Simpson’s rule and normalized to preinfarction
alues (15). Ejection fraction (EF) was calculated from
VESV and LVEDV. End-systolic muscle-to-cavity-area
atio (ESMCAR) and the circumferential length of the
osterolateral wall motion abnormality (WMA) at the high
apillary muscle level were also determined at each time
oint. The severity of mitral regurgitation (MR) was as-
essed quantitatively as the area of the regurgitant jet as a
ercentage of left atrial area in the apical four-chamber
iew. The following grading was used: grade 120%; grade
 20% to 40%, grade 3 40% to 60% and grade 460%
16).
ollow-up studies. Hemodynamic and echocardiographic
ata were collected at 30 min and two, five, and eight weeks
fter infarction. Following the eight-week study, the ani-
als were euthanized (80 mEq potassium chloride IV
olus). The heart was excised and photographed to confirm
nfarction size and location.
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February 4, 2004:377–83 Ischemic MR and Ventricular Remodelingtatistics. Measurements are reported as means  stan-
ard error of the mean. Between-group differences in all
ontinuous dependent variables (all but MR grade) are
ompared by analysis of variance for repeated measures. If
nalysis of variance (ANOVA) revealed significant differ-
nces, Student’s t test with the Bonferroni correction was
sed to assess differences between groups at specific time
oints post infarction (SPSS, Chicago, Illinois). For each
ignificantly different dependent variable a maximum of six
onferroni-corrected t tests were performed at a given time
oint. Differences in the degree of mitral regurgitation
etween groups were assessed using the nonparametric
ruskal-Wallis test. To evaluate the differences in MR
etween any two groups at specific time points the Mann-
able 1. Hemodynamic Data
SBP
(mm Hg)
LVEDP
(mm Hg)
CVP
(cm H2O)
CO
(1/min)
ontrol
Pre-infarction 106.2  12.1 5.0  4.0 12.1  4.7 3.5  1.1
Postinfarction 97.9  15.2 7.5  5.7 12.7  9.5 3.9  1.2
2 weeks 106.1  15.7 5.6  2.1 12.6  5.0 3.7  0.7
5 weeks 102.6  17.7 6.6  1.4 10.8  4.4 3.7  1.0
8 weeks 106.0  19.6 5.0  1.3 11.0  4.3 3.7  0.9
nnuloplasty
Pre-infarction 101.4  30.0 6.0  6.3 13.6  6.8 3.7  1.3
Postinfarction 97.4  15.8 6.0  4.6 11.0  5.1 3.3  1.0
2 weeks 88.8  5.1 6.2  9.0 12.0  8.6 2.8  1.4
5 weeks 95.2  9.5 7.0  1.9 10.0  1.4 3.4  1.0
8 weeks 99.2  11.7 6.2  2.3 14.6  5.0 3.2  1.3
esh wrap
Pre-infarction 99.1  19.8 4.3  3.2 12.3  2.5 3.1  0.6
Postinfarction 96.7  7.0 7.4  6.2 13.9  3.7 3.6  0.8
2 weeks 88.9  15.7 6.1  3.0 11.3  3.1 3.2  0.9
5 weeks 100.1  11.4 6.4  3.0 9.5  3.0 3.0  0.5
8 weeks 93.7  17.5 5.5  2.5 11.0  3.8 3.3  0.7
O  cardiac output; CVP  central venous pressure; LVEDP  left ventricular
nd-diastolic pressure; SBP  systolic blood pressure.
igure 1. Degree of mitral regurgitation (MR) graded on a scale of 0 to 4
circles), and ventricular wrap group (triangles). By the nonparametric
xperimental time points, the wrap, annuloplasty, and control groups are all sighitney test with the Bonferroni correction was used.
tatistical significance was established at p  0.05.
ESULTS
emodynamic data. No significant differences in LVEDP,
entral venous pressure, pulmonary artery diastolic pressure,
ean arterial pressure, or cardiac output were observed
etween groups at any of the time points studied (Table 1).
chocardiographic data. Echocardiographic data are sum-
arized in Table 1. As expected, the control group devel-
ped progressive and severe MR (3.4  0.3) during the
tudy period. The MR in the control group was significantly
ore than in either the annuloplasty (0.6 0.4) or the wrap
1.2  0.3) groups. There was no significant difference in
R between the annuloplasty and wrap groups at any
ndividual time point (Fig. 1).
Normalized LVESV at eight weeks was not altered by
rophylactic annuloplasty (2.05  0.29) when compared
ith controls (2.22  0.21). By ANOVA, considering all
xperimental time points, the wrap group was significantly
ifferent from both the control and annuloplasty groups
ith respect to LVESV (Fig. 2). Specifically, at eight weeks,
VESV in the wrap group (1.48  0.25) was significantly
educed when compared with the control group. Changes in
ormalized LVEDV followed a similar pattern (Table 2),
hough between-group comparisons did not reach statistical
ignificance.
End-systolic muscle-to-cavity-area ratio was preserved in
he wrap group, but decreased significantly in both the
nnuloplasty and control groups: there was a significant
ifference in the wrap group ESMCAR (1.63  0.14) at
ight weeks when compared with both the annuloplasty
1.09  0.17) and control (1.15  0.12) groups (Fig. 3).
he circumferential length of the akinetic segment of
no MR, 4  severe MR) in control group (squares), annuloplasty group
kal-Wallis test with MR as the dependent variable and considering all(0 
Krusnificantly different (p  0.05 for all comparisons).
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Ischemic MR and Ventricular Remodeling February 4, 2004:377–83yocardium at the high papillary muscle level (WMA) was
ignificantly reduced immediately after infarction in the
rap group (2.9  0.3 cm) when compared to both the
nnuloplasty (4.1  0.4 cm) and control (4.5  0.4 cm)
roups (Fig. 4), indicating that the wrap was effective in
educing early infarct expansion.
Ejection fraction was preserved in the wrap group (Fig.
). By ANOVA, considering all experimental time points,
he annuloplasty group EF was significantly worse than
oth the control and wrap groups with respect to EF. The
ontrol and wrap groups were not statistically different. By
able 2. Echocardiography Data
MR
Normalized
LVESV
ontrol group
Pre-infarction 0.5  0.2 1.00  0.00
Postinfarction 2.3  0.3* 1.29  0.10
2 weeks 2.6  0.3* 1.55  0.14
5 weeks 2.9  0.3* 1.89  0.16*
8 weeks 3.4  0.3* 2.22  0.21*
entricular wrap group
Pre-infarction 0.8  0.2 1.0
Postinfarction 1.1  0.3† 1.05  0.12
2 weeks 1.1  0.4† 1.22  0.17
5 weeks 1.3  0.3† 1.27  0.19†
8 weeks 1.2  0.3† 1.48  0.25†
nnuloplasty group
Pre-infarction 0.6  0.2 1.0
Postinfarction 0.8  0.4† 1.17  0.14
2 weeks 0.4  0.4† 1.58  0.20
5 weeks 0.4  0.4† 1.85  0.23*
8 weeks 0.6  0.4† 2.05  0.29*
p  0.05 compared to preinfarction within group, †p  0.05 compared to control gr
rror of the mean.
EF  ejection fraction; ESMCAR  end systolic myocardial to cavity area ratio
igure 2. Normalized left ventricular end systolic volume (LVESV) in con
triangles). The LVESV increased significantly in the control and annulop
onsidering all experimental time points, the wrap group was significantly
roup was not significantly different from the controls.olume; MR  Mitral regurgitation; WMA  posterior wall motion abnormality at the htudent’s t test (with Bonferroni correction), the EF was
ignificantly worse in the annuloplasty group at eight
eeks (25.3  2.9%) compared to the wrap group (36.5
2.4%).
ISCUSSION
ing annuloplasty was highly effective in preventing the
evelopment of IMR in this established ovine model;
owever, it had no demonstrable effect on postinfarction
entricular remodeling. In contrast, ventricular wrapping
alized
EDV ESMCAR
WMA
(cm)
EF
(%)
.0 1.68  0.12 0.0  0.0 42.4  2.6
0.08 1.29  0.08* 4.5  0.4 42.9  3.3
0.09 1.35  0.11* 4.3  0.3 36.6  2.7
0.11* 1.27  0.10* 4.5  0.4 31.0  2.2*
0.16* 1.15  0.12* 4.6  0.5 32.4  2.0
.0 1.58  0.15 0.0  0.0 38.9  3.1
0.10 1.66  0.11† 2.9  0.3†,‡ 44.8  4.0
0.11 1.44  0.13 2.8  0.2†,‡ 37.3  3.3‡
0.13 1.56  0.12 3.6  0.3 37.8  2.7‡
0.19 1.63  0.14†,‡ 3.2  0.4‡ 36.5  2.4‡
.0 1.76  0.17 0.0  0.0 36.7  3.7
0.11 1.28  0.13 4.1  0.4 32.1  4.7
0.13 1.27  0.15 4.4  0.3 25.6  3.9
0.16* 1.18  0.14 4.4  0.5 25.1  3.1
0.23* 1.09  0.17* 5.0  0.5 25.3  2.9
p  0.05 compared to annuloplasty group. All results expressed as mean  standard
DV  left ventricular end diastolic volume; LVESV  left ventricular end systolic
group (squares), annuloplasty group (circles), and ventricular wrap group
groups at eight weeks but not in the wrap group. By analysis of variance,
ent from both the annuloplasty and the control groups. The annuloplastyNorm
LV
1
1.29 
1.38 
1.54 
1.89 
1
1.17 
1.18 
1.24 
1.35 
1
1.08 
1.33 
1.53 
1.68 
oup, ‡
; LVEtrol
lasty
differigh papillary muscle level.
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February 4, 2004:377–83 Ischemic MR and Ventricular Remodelingeduced acute infarct expansion, preserved EF, and significantly
mproved measured parameters of postinfarction remodeling.
dditionally, ventricular wrapping was as effective as ring
nnuloplasty in preventing the development of IMR.
A potential limitation of this study was the fact that only
he ring annuloplasty group had open-heart surgery and the
ssociated need for a period of aortic cross-clamping with
rotected global ischemia. We were meticulously attentive
ith regard to myocardial protection during these proce-
ures. The fact that there was no statistical difference in the
reinfarction EF between groups indicates that intraopera-
ive myocardial protection was adequate.
igure 3. End-systolic muscle-to-cavity-area ratio (ESMCAR) in contr
triangles). The ESMCAR did not change during postinfarction remodeli
oints, ESMCAR was significantly reduced in both the annuloplasty and
ifference between the control and annuloplasty groups.
igure 4. Length of the circumferential wall motion abnormality at the hig
circles), and ventricular wrap group (triangles). By analysis of variance, c
he annuloplasty and control groups when compared to the wrap group. ThereClinically, IMR occurs most commonly after moderately
ized posterolateral infarctions involving the posterior pap-
llary muscle (4,5,17). The degree of mitral regurgitation is
ypically small initially but increases, often to severe levels,
ver a varying time course. The model of IMR used in this
xperiment faithfully replicates the human disease.
Recent laboratory (10,18) and clinical studies (11) have
hown that expansion (stretching) of a transmural MI initiates
progressive myopathic process in normally perfused myocar-
ium. This phenomenon is initially localized to myocardium
mmediately adjacent to the infarct, but extends during the
emodeling process to convert contiguous normally perfused
up (squares), annuloplasty group (circles), and ventricular wrap group
the wrap group. By analysis of variance, considering all experimental time
ol groups when compared with the wrap group. There was no significant
illary muscle level (WMA) in control group (squares), annuloplasty group
ering all experimental time points, the WMA was significantly greater inol gro
ng in
contrh pap
onsidwas no statistical difference between the control and annuloplasty groups.
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Ischemic MR and Ventricular Remodeling February 4, 2004:377–83yocardium into hypocontractile remodeled myocardium.
he stretch-induced myopathic process has been associated
ith myocyte apoptosis (14) and disruption of the extracellular
atrix secondary to activation of matrix metalloproteinases
19). The failure of surgical reshaping operations to improve
urvival in ischemic cardiomyopathy patients (20–22) strongly
uggests that infarct-induced myopathy is very difficult to
everse once established.
Using contrast echocardiography, Jackson et al. (23) has
emonstrated that early postinfarction geometric changes
onsistent with increased regional wall stress occur in the
orderzone region adjacent to infarcts undergoing early
xpansion and subsequent remodeling. A finite-element
nalysis by Guccione et al. (18) confirms these findings and
lso demonstrates that once the myopathic process is fully
eveloped, contractile function in nonischemic myocardium
s impaired beyond what would be expected from changes in
V geometry and stress distribution. Therefore, early after-
nfarction loss of contractility is due to mechanical factors;
s remodeling progresses the geometric contribution (stress)
o myocardial dysfunction is likely outstripped by the
yopathic phenomenon that it initiates in normally per-
used myocardium. It is for this reason that most operations
or established heart failure are ineffective. The salutary
ffect of ventricular wrapping demonstrated in this study is
ikely due to its ability to attenuate early infarct expansion,
hereby reducing adverse remodeling.
Elimination of moderate to severe ischemic mitral regur-
itation, either by valve replacement or valve repair, is an
ncreasingly recommended treatment for patients with
ymptomatic CHF (4,7). This trend has been driven by
mprovements in mitral valvuloplasty techniques and re-
uced perioperative mortality in patients with depressed
igure 5. Ejection fraction (EF) in control group (squares), annuloplas
onsidering all experimental time points, the EF in the annuloplasty grou
tatistical difference between the control and wrap groups.V function undergoing open-heart surgery. Recent large rlinical studies, however, fail to demonstrate that ad-
ressing chronic IMR adds to patient survival beyond
hat would be expected from optimal medical manage-
ent (4,7,8,24).
The primary intent of this study was to assess the relative
ontribution of infarct expansion and mitral regurgitation to
emodeling after posterior infarctions that are predisposed
o the development of progressive IMR. Our findings
ndicate that although chronic IMR is a manifestation of
ostinfarction LV remodeling it contributes minimally to
erpetuating the phenomenon of progressive LV dilation.
n the contrary, ventricular restraint that prevents infarct
xpansion dramatically influences the outcome of remodel-
ng and secondarily prevents the development of MR.
The preemptive and prophylactic surgical interventions used
n this study cannot, obviously, be directly applied clinically.
hey represent the best-case scenario of two very different
herapeutic strategies. The results of the study do, however,
ave important clinical implications. Our findings indicate that
elief (or prevention) of IMR has very little impact on remod-
ling. This helps to explain the negligible effect of mitral valve
eplacement or repair on survival in patients with IMR. This
tudy confirms the results of earlier experiments in our labo-
atory (13,25), and in doing so reinforces the thesis that
herapies that minimize infarct expansion early after acute MI
re more likely to limit adverse postinfarction remodeling and
hereby improve survival.
The threshold for surgical treatment of mitral regurgita-
ion caused by primary valvular disease is declining because
f improved repair techniques, reduced operative mortality,
nd proven benefits in reducing the incidence of irreversible
V dysfunction. Our data would caution against extrapo-
ating these results to patients with IMR. In IMR, mitral
rcles), and ventricular wrap group (triangles). By analysis of variance,
s significantly less than both the wrap and control groups. There was noty (ci
p waegurgitation is a consequence rather than a cause of
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February 4, 2004:377–83 Ischemic MR and Ventricular Remodelingostinfarction left ventricular remodeling. As these data
upport, the primary therapeutic target is early infarct
xpansion, not late mitral regurgitation.
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